BOSTON (Reuters) – The U.S. Justice Department on Wednesday sued Regeneron Pharmaceuticals Inc, accusing it of using a charity that helps cover Medicare patients’ drug costs as a means to pay kickbacks for using its expensive macular degeneration drug Eylea.
The government filed a lawsuit against the company in federal court in Boston, the latest case to result from an industry-wide probe of drugmakers’ financial support of patient assistance charities.
(Reporting by Nate Raymond in Boston; Editing by Chizu Nomiyama)
